Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 4938  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 2    

Recommend this journal


Year : 1998  |  Volume : 46  |  Issue : 2  |  Page : 130--133

Lamotrigene and vigabatrin in intractable seizures in children.

Department of Child Health, Sultan Qaboos University Hospital, Sultanate of, Oman

Correspondence Address:
RL Koul
Department of Child Health, Sultan Qaboos University Hospital, Sultanate of
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 29508802

Rights and PermissionsRights and Permissions

Twenty seven children with intractable seizures in the age group of 5 months - 14 years were treated with vigabatrin (VGB) and Lamotrigene (LTG) as an add-on therapy. Fourteen children (6M:8F) were given VGB and thirteen children (9M:4F) received LTG. The drug selection was made according to the type of seizures and associated neurological abnormalities. Attempt was made to exclude children with progressive neurologic disorders or severe systemic disease. EEG, CT scan head and relevant metabolic work up was done in all. VGB was found to be most effective in seizures associated with tuberous sclerosis. It was always useful in infantile spasm (IS) and tonic clonic (TC) seizures. LTG was effective in complex partial seizure (CPS) and TC seizures withmyoclonus.

[PDF Not available]*

Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow